Search

Your search keyword '"MATHEWS, ANNA WILDE"' showing total 9 results
Start Over Author "MATHEWS, ANNA WILDE" Journal wall street journal eastern ed
9 results on '"MATHEWS, ANNA WILDE"'

1. FDA signals it's open to drug trials that shift midcourse.

Author

Mathews AW

Subjects
Clinical Trials Data Monitoring Committees, Clinical Trials as Topic ethics, Clinical Trials as Topic legislation & jurisprudence, Data Interpretation, Statistical, Drug Evaluation methods, Drug Industry, Humans, Sample Size, United States, United States Food and Drug Administration, Clinical Trials as Topic methods, Research Design
Published
2006

3. Tricky FDA debate: should a risky drug be approved again?

Author

Mathews AW and Westphal SP

Subjects
Antibodies, Monoclonal, Humanized, Clinical Trials as Topic, Drug Labeling legislation & jurisprudence, Drugs, Investigational toxicity, Humans, Natalizumab, Patient Selection, United States, United States Food and Drug Administration, Antibodies, Monoclonal, Drug Approval legislation & jurisprudence, Drugs, Investigational adverse effects, Multiple Sclerosis drug therapy
Published
2006

5. Ghost story: at medical journals, writers paid by industry play big role.

Author

Mathews AW

Subjects
Biomedical Research ethics, Deception, Disclosure, Drug Industry ethics, Fraud, Humans, Research Personnel economics, Research Personnel ethics, Research Support as Topic, Scientific Misconduct, Authorship, Biomedical Research economics, Drug Industry economics, Editorial Policies, Journalism, Medical standards, Periodicals as Topic economics, Periodicals as Topic standards, Writing standards
Published
2005

7. Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.

Author

Mathews AW

Subjects
Antidepressive Agents economics, Antidepressive Agents therapeutic use, California, Clinical Trials as Topic standards, Cyclohexanols, Deception, Drug Industry, Duloxetine Hydrochloride, Humans, Publishing, Thiophenes, United States, Venlafaxine Hydrochloride, Biomedical Research standards, Cost Control, Drug Costs, Formularies as Topic, Health Maintenance Organizations, Insurance, Pharmaceutical Services, Marketing of Health Services, Research Design standards
Published
2005

8. Worrisome ailment in medicine: misleading journal articles; editors demand more data to ensure full disclosure of drug risks, trial gaps; Sarbanes-Oxley for professors.

Author

Mathews AW

Subjects
Academic Medical Centers, Authorship, Clinical Trials as Topic economics, Disclosure, Drug Industry, Research Design, Research Support as Topic, Clinical Trials as Topic standards, Drugs, Investigational adverse effects, Editorial Policies, Periodicals as Topic standards, Publication Bias
Published
2005

9. After Medtronic lobbying push, the FDA had change of heart.

Author

Mathews AW and Burton TM

Subjects
Aortic Aneurysm surgery, Information Dissemination ethics, Publication Bias, Stents adverse effects, United States, Equipment and Supplies adverse effects, Industry, Lobbying, Retraction of Publication as Topic, Safety, United States Food and Drug Administration
Published
2004

Catalog

Books, media, physical & digital resources
See catalog results